RANI — Rani Therapeutics Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $117.86m
- $121.30m
- $1.03m
Annual cashflow statement for Rani Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16.7 | -53.1 | -63.3 | -67.9 | -56.6 |
| Depreciation | |||||
| Non-Cash Items | 0.11 | 23.8 | 15.8 | 18 | 20.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.04 | -3.43 | 0.509 | -2.14 | -0.544 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -15 | -32.2 | -46.5 | -51.2 | -35.5 |
| Capital Expenditures | -1.2 | -0.506 | -1.62 | -1.23 | -0.268 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | -70.8 | 31.1 | 20.1 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -1.2 | -0.506 | -72.4 | 29.9 | 19.8 |
| Financing Cash Flow Items | — | — | -0.886 | -0.162 | -0.047 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 72.7 | 77.1 | 29 | 0.233 | 13.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 56.5 | 44.4 | -89.9 | -21.1 | -2.1 |